Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

Name: Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma
License: Public Domain

Dong Wen

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renal cell carcinoma (rcc), adjuvant

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 442101
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.